PMC:7195088 / 11079-11271 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":148,"end":163},"obj":"Body_part"},{"id":"T4","span":{"begin":167,"end":173},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"nakinra, Janus kinase family enzyme inhibitors) within RCT. This also applies to modifications of the immune response through high-dose intravenous immunoglobulins or plasma from convalescent "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T39","span":{"begin":167,"end":173},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"nakinra, Janus kinase family enzyme inhibitors) within RCT. This also applies to modifications of the immune response through high-dose intravenous immunoglobulins or plasma from convalescent "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T48","span":{"begin":29,"end":46},"obj":"Chemical"},{"id":"T49","span":{"begin":36,"end":46},"obj":"Chemical"}],"attributes":[{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_23924"},{"id":"A49","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"nakinra, Janus kinase family enzyme inhibitors) within RCT. This also applies to modifications of the immune response through high-dose intravenous immunoglobulins or plasma from convalescent "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":102,"end":117},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"nakinra, Janus kinase family enzyme inhibitors) within RCT. This also applies to modifications of the immune response through high-dose intravenous immunoglobulins or plasma from convalescent "}